Hung-ming M. Wang

8 East Street
Fengtai, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 219 publications

Corrigendum to "Androgen receptor may promote tumor progression via TTF-1/EGFR pathway in metastatic nasopharyngeal carcinoma" [Translational Oncology, Volume 65, March 2026, 102670].

Corrigendum to "Androgen receptor may promote tumor progression via TTF-1/EGFR pathway in metastatic nasopharyngeal carcinoma" [Translational Oncology, Volume 65, March 2026, 102670].

Journal: Translational oncology

Published: April 18, 2026

SSTR2-targeting therapy in EBV-positive and EBV-negative metastatic nasopharyngeal carcinoma.

SSTR2-targeting therapy in EBV-positive and EBV-negative metastatic nasopharyngeal carcinoma.

Journal: American journal of cancer research

Published: December 25, 2025

Serum Metabolomics for Prognostic Stratification in Resected Advanced-Stage Oral Cavity Cancer.

Serum Metabolomics for Prognostic Stratification in Resected Advanced-Stage Oral Cavity Cancer.

Journal: JAMA otolaryngology-- head & neck surgery

Published: December 04, 2025

Surgery alone achieves comparable survival to adjuvant therapy in T4aN0M0 gingival squamous cell carcinoma with clear surgical margins: A registry-based propensity-matched analysis.

Surgery alone achieves comparable survival to adjuvant therapy in T4aN0M0 gingival squamous cell carcinoma with clear surgical margins: A registry-based propensity-matched analysis.

Journal: Oral oncology

Published: October 29, 2025

Effects of Mechanical Isolation of Stromal Vascular Fraction Combined With Mori Cortex Extract on Wound Healing.

Effects of Mechanical Isolation of Stromal Vascular Fraction Combined With Mori Cortex Extract on Wound Healing.

Journal: Annals of plastic surgery

Published: October 01, 2025

Androgen receptor may promote tumor progression via TTF-1/EGFR pathway in metastatic nasopharyngeal carcinoma.

Androgen receptor may promote tumor progression via TTF-1/EGFR pathway in metastatic nasopharyngeal carcinoma.

Journal: Translational oncology

Published: August 23, 2025

Outcome of T2 Glottic Cancer Treated with Radiotherapy Alone or Concurrent Chemo-Radiotherapy.

Outcome of T2 Glottic Cancer Treated with Radiotherapy Alone or Concurrent Chemo-Radiotherapy.

Journal: Cancers

Published: January 26, 2025

Therapeutic stress triggers tumor STAT1 acetylation to disarm immunotherapy.

Therapeutic stress triggers tumor STAT1 acetylation to disarm immunotherapy.

Journal: Cell reports. Medicine

Published: January 12, 2025

The Use of an Integrated Digital Tool to Improve the Efficiency of Multidisciplinary Tumor Boards-A Prospective Trial in Taiwan.

The Use of an Integrated Digital Tool to Improve the Efficiency of Multidisciplinary Tumor Boards-A Prospective Trial in Taiwan.

Journal: Cancers

Published: December 18, 2024

Pathological primary tumor status, rather than adjuvant therapy, predicts survival outcomes in pT1-3N1M0 oral cavity squamous cell carcinoma: A nationwide cohort study.

Pathological primary tumor status, rather than adjuvant therapy, predicts survival outcomes in pT1-3N1M0 oral cavity squamous cell carcinoma: A nationwide cohort study.

Journal: Oral oncology

Published: December 09, 2024

Prognostic significance of diagnosis-to-surgery interval in oral cavity squamous cell carcinoma: A nationwide study.

Prognostic significance of diagnosis-to-surgery interval in oral cavity squamous cell carcinoma: A nationwide study.

Journal: Oral oncology

Published: November 29, 2024

Is postoperative adjuvant therapy necessary for pT3N0 oral cavity squamous cell carcinoma?

Is postoperative adjuvant therapy necessary for pT3N0 oral cavity squamous cell carcinoma?

Journal: Oral oncology

Published: November 10, 2024

Showing 1-12 of 219

Last Updated: 09/26/2026